CD4 and lung cancer: CD8+ T cells producing CXCL13 were reported in lung cancer (30) and ovarian cancer (31, 45), whereas an analysis in nasopharyngeal cancer reported that most subsets of T cells producing CXCL13 were CD4+ T cells (33).